Genomic Valley Biotech informs about disclosure

07 Oct 2019 Evaluate

Genomic Valley Biotech has informed about the disclosures of reasons for encumbrance by promoter of listed companies under Regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 06, 2019 for Yogesh Agrawal. 

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

25.12 0.12 (0.48%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1299.70
Mangalam Global Ent 10.21
Kaveri Seed 806.95
Regaal Resources 63.87
Simran Farms 153.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×